EQS-News: Alzchem Group AG
/ Key word(s): Sustainability
Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand Trostberg, June 7, 2024 – Alzchem has received funding commitments totaling around EUR 850 thousand, which represent non-repayable investment grants this year. Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, continues to consistently implement its ambitious climate roadmap. On the way to climate neutrality by 2033, the company is implementing various measures to save energy, recover heat and increase efficiency. Alzchem is also supported in this by the Federal Office for Economic Affairs and Export Control (“Bundesamt für Wirtschaft und Ausfuhrkontrolle”, BAFA). So far this year, Alzchem has received funding commitments totaling around EUR 850 thousand, which represent non-repayable investment grants. Andreas Niedermaier, CEO of Alzchem Group AG: “We are delighted about the government recognition and support for our efforts to promote climate protection and reduce our CO2 emissions. We are convinced that specialty chemicals can make an important contribution to sustainability. To this end, we will continue to work on innovative solutions that make both economic and ecological sense. The current status of our climate roadmap was presented in detail at the Annual General Meeting on May 7, 2024, and can also be viewed on our website.” Alzchem Group AG had already presented its climate roadmap extensively to its shareholders at the Annual General Meeting 2023 and was the first German listed company to obtain a “Say on Climate” resolution from its shareholders. The complete climate roadmap is available for download on the website www.alzchem.com in the Sustainability section.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023.
07.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 1920871 |
End of News | EQS News Service |
|
1920871 07.06.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.